Sippican Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.83M Hold
22,030
1.73% 16
2026
Q1
$2.65M Sell
22,030
-446
-2% -$51.5K 1.81% 16
2025
Q4
$2.37M Sell
22,476
-650
-3% -$61K 1.52% 21
2025
Q3
$1.94M Buy
23,126
+943
+4% +$77.7K 1.28% 26
2025
Q2
$1.76M Sell
22,183
-85
-0.4% -$6.76K 1.28% 29
2025
Q1
$2M Buy
22,268
+850
+4% +$79.4K 1.51% 19
2024
Q4
$2.13M Buy
21,418
+750
+4% +$77.3K 1.55% 19
2024
Q3
$2.35M Sell
20,668
-10
-0% -$1.19K 1.64% 19
2024
Q2
$2.56M Sell
20,678
-3
-0% -$386 2.03% 11
2024
Q1
$2.73M Sell
20,681
-2,284
-10% -$282K 2.12% 10
2023
Q4
$2.5M Buy
22,965
+1,732
+8% +$180K 1.96% 9
2023
Q3
$2.19M Buy
21,233
+300
+1% +$32.3K 1.97% 8
2023
Q2
$2.42M Sell
20,933
-603
-3% -$68.5K 2.23% 5
2023
Q1
$2.29M Sell
21,536
-1,902
-8% -$205K 2.19% 7
2022
Q4
$2.6M Sell
23,438
-631
-3% -$64.5K 2.49% 5
2022
Q3
$2.07M Sell
24,069
-815
-3% -$72.8K 2.16% 8
2022
Q2
$2.27M Sell
24,884
-140
-0.6% -$12.4K 2.25% 7
2022
Q1
$2.05M Buy
25,024
+576
+2% +$45.4K 1.7% 15
2021
Q4
$1.87M Buy
24,448
+661
+3% +$52.6K 1.59% 18
2021
Q3
$1.79M Buy
23,787
+1,420
+6% +$108K 1.55% 21
2021
Q2
$1.74M Buy
22,367
+944
+4% +$70.2K 1.51% 21
2021
Q1
$1.58M Buy
21,423
+2,231
+12% +$165K 1.46% 28
2020
Q4
$1.5M Sell
19,192
-2,554
-12% -$195K 1.63% 18
2020
Q3
$1.72M Buy
21,746
+1,312
+6% +$103K 2.14% 10
2020
Q2
$1.51M Sell
20,434
-1,014
-5% -$76.3K 2.03% 10
2020
Q1
$1.57M Sell
21,448
-1,275
-6% -$100K 2.57% 6
2019
Q4
$1.97M Buy
22,723
+45
+0.2% +$3.7K 2.19% 8
2019
Q3
$1.82M Sell
22,678
-1,052
-4% -$84.3K 2.2% 6
2019
Q2
$1.9M Sell
23,730
-3,048
-11% -$233K 2.24% 8
2019
Q1
$2.13M Sell
26,778
-3,144
-11% -$235K 2.53% 5
2018
Q4
$2.18M Buy
29,922
+334
+1% +$23.6K 2.95% 4
2018
Q3
$2.13M Sell
29,588
-2,289
-7% -$146K 2.47% 6
2018
Q2
$1.85M Sell
31,877
-78
-0.2% -$4.4K 1.85% 15
2018
Q1
$1.66M Buy
31,955
+2,449
+8% +$132K 1.72% 16
2017
Q4
$1.58M Buy
29,506
+9,182
+45% +$509K 1.55% 20
2017
Q3
$1.24M Buy
20,324
+3,447
+20% +$209K 1.27% 33
2017
Q2
$1.03M Buy
16,877
+50
+0.3% +$3.04K 1.12% 33
2017
Q1
$1.02M Sell
16,827
-8
-0% -$485 1.08% 36
2016
Q4
$946K Sell
16,835
-3,068
-15% -$180K 0.99% 37
2016
Q3
$1.19M Hold
19,903
1.35% 29
2016
Q2
$1.09M Sell
19,903
-733
-4% -$39K 1.3% 31
2016
Q1
$1.04M Buy
20,636
+416
+2% +$20.4K 1.33% 28
2015
Q4
$1.02M Buy
20,220
+183
+0.9% +$9.23K 1.29% 29
2015
Q3
$944K Sell
20,037
-288
-1% -$15.3K 1.2% 32
2015
Q2
$1.1M Sell
20,325
-371
-2% -$20.8K 1.11% 32
2015
Q1
$1.14M Buy
20,696
+288
+1% +$16.3K 1.16% 29
2014
Q4
$1.11M Sell
20,408
-733
-3% -$40.8K 1.1% 29
2014
Q3
$1.2M Buy
+21,141
New +$1.19M 1.22% 29

Other funds holding MRK

Sippican Capital Advisors's MRK Position: Q2 2026 in Review

Sippican Capital Advisors held its Merck (MRK) position steady in Q2 2026 at 22,030 shares worth $2.83M. The position accounts for 1.73% of the portfolio, ranked #16.

Sippican Capital Advisors first reported a position in MRK in Q3 2014 and has held it in 48 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sippican Capital Advisors held 22,030 shares of Merck worth $2.83M as of Q2 2026.
  • Sippican Capital Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 1.73% of Sippican Capital Advisors's portfolio in Q2 2026, its #16 holding.
  • Sippican Capital Advisors first reported a position in Merck in Q3 2014 and has held it in 48 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sippican Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.